LIDOCAINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for lidocaine hydrochloride and what is the scope of freedom to operate?
Lidocaine hydrochloride
is the generic ingredient in thirty-five branded drugs marketed by Thea Pharma, Carlisle, Abbott, Abraxis Pharm, Afaxys, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Mankind Pharma, Miles, Rising, Sintetica Us, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Hikma, Pharmaton, Meridian Medcl Techn, Astrazeneca, Dentsply Pharm, Bionpharma, Sagent Pharms Inc, Cosette, Sentiss, Watson Labs Inc, Rubicon, Wockhardt Bio Ag, Actavis Mid Atlantic, Chartwell Molecular, Pai Holdings Pharm, Kendall Il, Lannett Co Inc, Novitium Pharma, Paco, Taro, The J Molner, Powder Pharms, and Pfizer, and is included in one hundred and thirteen NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Lidocaine hydrochloride has nineteen patent family members in ten countries.
There are nine drug master file entries for lidocaine hydrochloride. Fifty-three suppliers are listed for this compound.
Summary for LIDOCAINE HYDROCHLORIDE
International Patents: | 19 |
US Patents: | 4 |
Tradenames: | 35 |
Applicants: | 54 |
NDAs: | 113 |
Drug Master File Entries: | 9 |
Finished Product Suppliers / Packagers: | 53 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 1,820 |
Patent Applications: | 5 |
What excipients (inactive ingredients) are in LIDOCAINE HYDROCHLORIDE? | LIDOCAINE HYDROCHLORIDE excipients list |
DailyMed Link: | LIDOCAINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sichuan Cancer Hospital and Research Institute | N/A |
Jessyka Lighthall | Phase 3 |
Sawanpracharak hospital | N/A |
Pharmacology for LIDOCAINE HYDROCHLORIDE
Drug Class | Amide Local Anesthetic Antiarrhythmic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for LIDOCAINE HYDROCHLORIDE
US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | XYLOCAINE | lidocaine hydrochloride | INJECTABLE;INJECTION | 006488-010 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | LIDOCAINE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 088802-001 | Apr 26, 1985 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abraxis Pharm | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 086761-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 080377-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Intl Medication | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 086389-001 | Feb 2, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fresenius Kabi Usa | XYLOCAINE PRESERVATIVE FREE | lidocaine hydrochloride | INJECTABLE;INJECTION | 016801-005 | Jan 19, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 083158-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIDOCAINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Powder Pharms | ZINGO | lidocaine hydrochloride | SYSTEM;INTRADERMAL | 022114-001 | Aug 16, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LIDOCAINE HYDROCHLORIDE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2043601 | FORMULATION DE GEL AQUEUX ET PROCÉDÉ POUR INDUIRE UNE ANESTHÉSIE TOPIQUE (AQUEOUS GEL FORMULATION AND METHOD FOR INDUCING TOPICAL ANESTHESIA) | ⤷ Sign Up |
United Kingdom | 0708758 | ⤷ Sign Up | |
South Korea | 101845648 | ⤷ Sign Up | |
Taiwan | 200916139 | Particle cassettes and processes therefor | ⤷ Sign Up |
Taiwan | 201540331 | Device for delivering particles | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2015130961 | ⤷ Sign Up | |
Japan | 6369551 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.